Renal damage was assessed by histopathology and urinalysis in male Wistar rats treated with either hexachloro-1:3-butadiene (HCBD; a single 170-mg/kg ip dose that caused proximal tubule necrosis), adriamycin (ADR; a single 5-mg/kg ip dose that caused minimal glomerular changes up to 35 days), or HCBD given 2 wk after ADR and compared with age-matched control rats for 21 days. Urinalysis values in ADRtreated rats showed minimal renal changes. HCBD significantly elevated urine volume (10-fold), protein (5fold), glucose (175-fold), and brush border enzymes (10-600-fold), indicating severe proximal tubular damage, but most parameters returned to pretreatment levels 6 days after treatment. In ADR-pretreated rats subsequently given HCBD, both the urinary alkaline phosphatase and the ratio of kidney : body weight were significantly higher for longer periods. Histopathology demonstrated that the HCBD-induced proximal tubular lesion was confined to the outer stripe of the outer medulla. Advanced regeneration and repair was evident 21 days after HCBD treatment. In the ADR-pretreated rats the HCBD-induced lesion was more severe and affected the entire cortex and was characterized by marked tubular epithelial calcification, with little evidence of repair and tubular restitution 21 days after treatment. Enzyme histochemistry showed &gamma;glutamyltranspeptidase localized to the proximal tubules. After HCBD treatment the enzyme staining was lost and subsequently returned in parallel with histological recovery up to 21 days. The distribution and intensity of &gamma;-glutamyltranspeptidase was unchanged in ADR-treated rats. The distribution and intensity of &gamma;-glutamyltranspeptidase in kidneys of ADR-pretreated rats given HCBD had not returned to normal by day 21. The results of this study indicate that pretreatment with ADR increases HCBD-induced nephrotoxic damage and decreases renal cortical repair capacity.
INTRODUCTION
An existing nephropathy or age-related kidney degeneration can increase the risk of renal injury and exacerbate nephrotoxicity in humans (16, 59) . Preexisting renal injury may also increase nephrotoxic effects in experimental models. For example, rats previously treated with aminoglycosides have increased sensitivity to nephrotoxic agents (32, 45) .
Potassium dichromate enhances or potentiates the nephrotoxic effects of mercuric chloride, citrinin, and maleic acid (12) . Furthermore, the co-administration of several compounds (including mycotoxins) may interact to cause renal injury additively or synergistically (1) .
There are, however, examples where the injured kidney is refractory to subsequent chemical insult. Examples of this include resistance to gentamycin nephrotoxicity, which has been demonstrated in partially nephrectomized rats (11) , as well as in rats recovering from acute tubular necrosis due to preexposure to tubular toxins such as mercuric chloride (42) , uranyl nitrate, potassium dichromate, and glycerol (15) . In addition, chronic exposure of rats to heavy metals such as cadmium, lead, inorganic mercury, or potassium dichromate does not increase toxicity resulting from subsequent exposure to gentamycin or hexachlorobutadiene (28, 29, 34, 60) .
Glomerulopathies are common in humans (9) , but the sensitivity of such compromised kidneys to nephrotoxic chemicals have not been well documented. An enhanced proximal tubule sensitivity to gentamycin has been demonstrated in rats with polyvinyl alcohol-induced benign glomerulopathy (10) as well as in acute canine nephrotoxic glomerulonephritis (57, 58) . These experimental studies suggest that patients with compromised glomerular function may be more sensitive to nephrotoxins.
The objective of this study was to examine the influence of compromised glomerular function arising from a rat model of nephrotic syndrome on the sensitivity of the renal proximal tubule to a chemical insult, which would normally recover. Adriamycin (ADR) was selected as it produces a discrete glomerular lesion following a single dose. This model nephrotic syndrome has been well characterized in terms of proteinuria, hypoalbuminemia, and peripheral edema (3, 20, 54) in susceptible species such as rats and rabbits. Hexachloro-1:3-butadiene (HCBD) was selected to produce a discrete lesion characterized by necrosis of the straight portion (pars recta) of the proximal tubule (2, 39) . An important feature of this model is that both morphology and renal function are normal within 21-28 days after treatment (39) . Furthermore, the lesion is well documented in terms of increased urinary protein, glucose, and transient increases in enzymes such as alanine aminopeptidase (AAP), N-acetyl-#-D-glucosamine, alkaline phosphatase (ALP), and y-glutamyltranspeptidase (GGT) (21 ) .
Investigations into the mechanisms of nephrotoxicity in the functionally compromised kidney are complicated by its dynamic response to injury and require the use of both functional and structural data at a series of time points if they are to fully characterize molecular changes. This investigation used noninvasive biochemical markers of renal injury and both morphology and enzyme histochemistry to show that an existing ADR-induced nephrosis increases the sensitivity of the proximal tubule to HCBD-induced toxic damage and also decreases the renal cortical repair capacity. Refinement of the model used in this study will provide the basis to increase our understanding of the factors that determine sensitivity to nephrotoxins, thereby aiding in the identification of high-risk situations for those individuals who may be exposed to potentially nephrotoxic compounds.
MATERIALS AND METHODS
Chemicals and Reagents. All reagents were of analytical standard and of the highest purity available commercially. Special chemicals were as follows ; ADR (Carlo Erba, Bamet, Herts, UK) and spectroscopic grade HCBD (BDH, Poole, Dorset, UK), L-alanine-p-nitroaniline (Sigma Chemical Co., Poole, Dorset, UK), glycolmethacrylate resin (JB-4 resin, Polysciences, Northampton, UK), and glutamyl-~3-naphthylamide (Koch-Light, Haverhill, Suffolk, UK). GGT and glucose were analyzed using a Cobas Bio-centrifugal autoanalyzer and reagent kits (Roche Diagnostics, Welwyn Garden, Hertfordshire). Animals Maintenance. All investigations complied with the regulations laid down by the UK Home Office under the Animal Scientific Procedures Act ( 1986) . Male Wistar rats, with an initial body weight of 80-100 g, had free access to food (Lab Diet No. 1, Spratts, Barking, Essex, UK) and tap water prior to the experiment. The rats were housed in groups of 10 in translucent &dquo;shoe-box&dquo;-type plastic cages (60 x Experimental Design and Treatment of Animals. Animals were randomly assigned to treatment groups consisting of ADR only (ADR-5 mg/kg body weight in normal saline, administered as a single ip dose); HCBD only (HCBD-170 mg/kg body weight in peanut oil, administered as a single ip dose); ADR followed 2 wk later by HCBD (ADR/HCBD); and untreated controls. The animals had an average weight of 200 g when the HCBD was given. Animals were injected ip between 0800 and 0830 hr.
Urine Collection and Urinalysis. Three animals from each group were randomly assigned to urinalysis studies for the full duration of the investigation. Urine was collected at 0-5°C in glass metabolism cages over an 18-hr period for 3 consecutive days beginning on days 1, 8, 11, 16, and 22 following HCBD treatment in the ADR/HCBD and HCBD groups and at corresponding time points in agematched animals in ADR and control rats. Urinalysis was also performed on animals in the ADR group at days 12, 13, 14, and 17, 18, 19 following ADR administration. Urine samples were kept at 0-5°C for the duration of the collection period. Subsequently, the urine volumes were measured and the samples centrifuged at 3,000 rpm for 10 min, to separate debris and particulate matter. After this period, animals were transferred to plastic cages (North Kent Plastic Cages Ltd., GSI) where food was freely available for a 6-hr period (1000-1600 hr) each day. Tap water was supplied ad libitum throughout the experiment.
Urinary glucose was measured enzymically by the hexokinase method (6) . Proximal tubule marker enzymes AAP (48) , GGT (50) , and ALP (22, 23) were assessed kinetically and expressed as units ( U corresponds to a 1 ~mo1/min substrate conversion) of enzyme activity per 18-hr urine volume. The remaining samples were kept frozen at -20°C until proteins were measured by the biuret reaction (33) .
Morphology and Histopathology. Three animals a in the HCBD and ADR/HCBD groups were weighed t and then killed by cervical dislocation at 1, 2, 3, 7, 14, and 21 days after treatment with HCBD. Control I animals and those treated with ADR alone (n = 3 per group) were killed at 3, 7, and 14 days in parallel 1 2 mm) were washed in 0.1 M phosphate buffer (pH chemical distribution of GGT was assessed using a 6-hr incubation period at 37°C with glutamyl-¡3-naphthylamide as the substrate based on the method of Pearse (56), as described by Gregg et al (24) .
Statistics. Statistically significant differences between groups were determined by 2-tailed Students' t-test, with p < 0.05 considered to be statistically significant.
RESULTS

Urinanalysis
There were no significant differences in the urinary parameters in the control and ADR groups (Table I ). In the group treated with HCBD alone urine volume rose 10-fold within 24 hr of treatment and remained elevated for 4 days posttreatment. Mean urine concentrating capacity (specific gravity, SG) dropped markedly 24 hr after treatment and returned to control levels 4 days later. There was an approximately 5-fold increase in urinary protein and a 175-fold increase in urinary glucose that remained elevated between 3 and 7 days after treatment. Twenty-four hours after treatment with HCBD, there were marked increases in AAP (10fold) and ALP (600-fold), which returned to control levels 2 days following HCBD.
Urine volume, SG, protein, glucose, and AAP in rats in the ADR/HCBD group did not vary significantly from rats treated with HCBD alone (Table   1 ). However, levels of ALP remained elevated for L longer period (i.e., approximately 5 days) in rats reated with ADR/HCBD compared to HCBD alone. 7ross Morphology ADR had no effect on the gross kidney appearance )r weight. Kidneys were pale and enlarged in aninals in the HCBD group. The kidney to body weight 'atio increased to twice that of controls by day 3 )osttreatment with HCBD but had returned to nornal by day 7 (data not shown). Kidneys were enarged and pale with cloudy white renal capsules in .he ADR/HCBD group, where the kidney to body weight ratio was approximately twice that of controls 21 days after treatment with HCBD (data not 3hown).
Yistopa th o logy
There were no renal lesions visible by light mioroscopy after ADR treatment. Twenty-four hr after treatment with HCBD alone, a distinct band of necrosis was visible in the outer stripe of the outer medulla and extended in medullary rays into the outer cortex ( Fig. 1 a) . Tubules were dilated and filled with homogenous eosinophilic material and necrotic epithelial cells. Signs of regeneration and restitution (i.e., tubular re-epithelialization and loss of tubular casts and debris) were evident by day 7 and complete 21 days after treatment (Fig. 1 b) .
Histologically, animals in the ADR/HCBD group showed much more extensive renal damage ( Fig.  2a ) when compared to those treated with HCBD alone (see Fig. 1 a) . Extensive tubular damage was present throughout the entire cortex 2 days after HCBD treatment, and tubules were dilated and filled with homogeneous proteinaceous material. Sloughed necrotic calcified epithelial cells were observed in tubular lumens and casts extended deep into the medulla (Fig. 2b) . Extensive calcification was evident by day 7 (which was not seen in the HCBD only group) and by day 21, regeneration, although apparent, was less advanced and marked tubular calcification was still evident (Fig. 2c) . Table 2 summarizes the differences between the ADR/HCBD group and HCBD alone.
Histochemistry
Control kidneys demonstrated normal GGT staining of the tubular epithelium of the outer stripe of the outer medulla (Fig. 3a) . ADR caused no changes in this staining pattern. GGT staining in the outer stripe of the outer medulla was diminished TABLE I.-Time course changes in urine markers of renal injury in animals exposed to either HCBD or ADR alone or ADR followed by HCBD and compared to age-matched controls. I Time relative to treatment with HCBD (ADR/HCBD and HCBD groups only). Time points in control and ADR groups were matched according to age. Values represent the mean ± SD of urinalysis values from 3 rats.
Significantly different from control group, and from HCBD groupb p < 0.05.
( Fig. 3c ) compared to HBCD only treatment or controls.
DISCUSSION
The results of this study show an enhanced nephrotoxic effect of HCBD in ADR-pretreated rats than that caused by HCBD treatment alone. This conclusion is based on the reproducible findings of a more extensive and severe renal tubular lesion in ADR-pretreated rats that were subsequently treated with HCBD, than was the case for HCBD alone.
Histopathology and enzyme histochemistry most clearly demonstrated the increased severity of HCBD-induced renal lesions in the ADR-pretreated rats and the incapacity for repair. The lack of histologic evidence of repair and tubular restitution and the increased kidney to body weight ratio at day 21 after HCBD treatment supports the hypothesis that ADR pretreatment either exacerbates tubular damage and/or retards the rate of repair. Of the biochemical parameters analyzed only the prolonged elevation of alkaline phosphatase alluded to a more extensive lesion in ADR-pretreated rats. The lack of statistically significant differences in the urinalysis parameters in rats treated with ADR/HCBD and HCBD was likely due to the large variance. This lack of predictability of urinalysis data is consistent with other studies where there has been considerable variation within and between groups of control rats (17) . This unpredictability makes the correlation of enzymuria data and histology and histochemistry difhcult.
The marked increases in urine volume, protein, glucose, and urinary enzymes, as well as the decrease in urinary SG and elevated kidney: body weight ratio in rats treated with HCBD, are indicative of acute tubular necrosis and are consistent with previous studies (39, 40) . Similarly, the return of renal mark- ers of injury and the kidney: body weight ratio, to within control range by day 11 show that considerable repair of renal damage was occurring. This is supported by histological evidence of regeneration of tubular epithelium and return of normal GGT staining in proximal tubules by 21 days after HCBD treatment. This is consistent with magnetic resonance imaging analysis of HCBD-treated rats, which indicated that full recovery of tubular damage occurred within 28 days of treatment (18) .
HCBD is a useful model toxin for damaging the proximal tubule. It is metabolized in the liver, ex- The extent of renal proximal tubular damage and regeneration was assessed based on the following criteria; +, minimal, involving isolated proximal tubules; + +, moderate, involving several proximal tubules; + + +, extensive, involving the majority of proximal tubules. OSOM = outer stripe of the medulla. ) and epithelial calcification (c). Giemsa. x 40. creted in the bile as an HCBD-glutathione (GSH) conjugate (52) , and transported to the kidney where it is converted to a cysteine conjugate by the enzymes GGT and cysteinyl glycinase, which are concentrated to a great extent in the pars recta of the proximal tubules (13, 14, 38, 49, 61) . In the epithelial cells of the S3 segment the cysteine conjugate undergoes acetylation and activation by the enzymẽ i-lyase, thereby generating a reactive thio-chlorobutadiene moiety. This moiety is capable of alkylating cellular macromolecules resulting in necrosis of this segment (39) . Although other segments are known to be affected (40) , metabolic activation due to the presence of 0-lease in the S3 segment (pars recta) is thought to be the reason for its vulnerability (39, 44) .
ADR-induced nephrosis is characterized by proteinuria, hypoproteinemia, and peripheral edema (4, 7, 26, 51 ) , which are only evident several weeks after treatment (5, 8) . Light microscopic pathology of an ADR-exposed kidney is normal. Severe ultrastructural glomerular epithelial cell changes occur soon after insult and provide the basis for the increased glomerular permeability and the high molecular weight proteinuria (3, 26, 43, 51) . Fibrosis or sclerosis of glomeruli develops after extended pe-riods (27) . Although it has been suggested that ADR might also cause tubular toxicity (36) , it is generally accepted that the tubular effects of such exposure are minor, short-lived, and unimportant. In addition, in vitro investigations have demonstrated that freshly isolated proximal tubular fragments are much less sensitive to the cytotoxic effects of ADR than isolated glomeruli (30, 31 ) . The dose chosen in this study caused minimal changes in urinary protein up to 35 days, after which time proteinuria became increasingly apparent.
The mechanism of the enhanced toxicity of HCBD in ADR-pretreated rats in this study is unclear; however, there are several plausible hypotheses. Significant absorption and metabolism of protein occur along the proximal tubule, and the absorption rate varies according to the proximal tubular protein concentration (46) . Micropuncture studies have demonstrated that single nephron albuminuria is increased after reduction of nephron number in rats with ADR nephrosis (37, 47, 53) . Results from other studies have suggested that proteinuria in ADRinduced nephrosis might be an important mediator oftubulointerstitial damage (4). Thus the combined effect of HCBD on an ADR-induced lesion would produce a protein or solute overload such that the   FIG. 3. -a) Kidney from control rat showing normal staining for GGT in the tubular epithelium of the outer stripe of the outer medulla. GGT. x 40. b) Kidney 3 days after treatment with HCBD showing faint regeneration of staining in some regions of the outer stripe of the outer medulla. GGT. x 40. c) Minimal staining for GGT in outer stripe of the outer medulla of kidney of ADR-pretreated rat 3 wk after treatment with HCBD. GGT. x 40. 1 reabsortive capabilities of the S 1 and S2 tubule segments might be exceeded. Clearing a protein or solute overload would stress the mitochondrial energygenerating capacity and result in the release of bound Ca 2+ . The reactive thiol moiety of HCBD also causes mitochondrial dysfunction (41) . Moreover, inhibition ofglutathione reductase activity in the renal cortex of rats within an hour after HCBD has led to the suggestion that renal mitochondrial proteins might also be a target (41 ) . Depletion of intracellular GSH following exposure to both ADR and HCBD may also result in Ca2+ loss. Perturbation of intracellular Ca2+, together with loss of cellular thiols, plays an important role in irreversible changes that lead to cell death (55) . The extensive calcification of tubular epithelial cells in rats in the ADR/HCBD group supports this hypothesis.
The diversity of human nephropathies and the varied potency and site-specificity of toxic chemicals makes it unlikely that any one model will adequately reflect all disease-related changes that alter the renal response to nephrotoxins. For example, the potentiation of the nephrotoxic effect of aminoglycosides in combination with cephalosporin in humans has not been demonstrated in experimental animals (25, 35) . This is generally explained by the fact that laboratory animals do not have the underlying disease processes, which necessitate antibiotic administration (32) . Furthermore, it is di~cult to ascertain the degree of functional impairment induced in experimental nephrosis since standard renal function tests such as glomerular filtration rate and creatinine clearance only measure changes beyond a critical limit (usually estimated to be 75%). The limitations in detecting subclinical changes in renal function make it difficult to select nephrotoxins and dose levels when attempting to produce models of renal compromization. In spite of the inherent problems in developing experimental models they fulfill the fundamental need to investigate the mechanisms of nephrotoxicity in the compromised kidney as the basis to identify potentially susceptible individuals. Further development and refinement of models such as the one presented in this study will aid in this objective.
